Retinal Microvascular Alterations in Patients with Quiescent Posterior and Panuveitis Using Optical Coherence Tomography Angiography

Abstract

Purpose: To quantify retinochoroidal vascular parameters using swept-source optical coherence tomography (SS-OCTA) in quiescent posterior and panuveitis. Methods: In this cross-sectional study, subjects with quiescent posterior and panuveitis underwent fundus imaging using SS-OCTA (DRI Triton®, Topcon, Japan). The metrics calculated were fractal dimension (FD), foveal avascular zone (FAZ) area, retinal vascularity index (capillary density index-CDI), and choroidal vascularity index (CVI). Results:We included 38 eyes of 20 patients, 9 males aged 34.7 ± 10.5 years, 30 eyes of 30 age-and gendermatched healthy controls, 10 females aged 33.6 ± 8.5 years. Comparing patients with controls, we found a lower FD (p < .001), larger FAZ (p > .001), lower CDI in the superficial plexus (p = .019), and lower CVI (p < .001). We also found lower retinal and choroidal and thicknesses (p < .001 and p = .025, respectively). Conclusions: Patients with quiescent posterior and panuveitis have a significantly reduced retinochoroidal vascular density compared to healthy control subjects.

Swept-source optical coherence tomography angiography of retinal occlusive vasculitis following brolucizumab administration: a case report

“…OCTA can provide high-resolution images of individual vascular plexuses in different retinal layers in a noninvasive manner. Previous studies have shown that OCTA plays an important role in the diagnosis and treatment of uveitis [ 21 – 24 ]. OCTA appears to be particularly useful for a detailed evaluation of retinal nonperfusion as well as improvement of retinal ischemia after treatment.…”

Interpreting posterior uveitis by integrating indocyanine green angiography, optical coherence tomography, and optical coherence tomography angiography data: A narrative review

“…The pathological process associated with uveitis includes inflammation, vascular leakage and occlusion, local ischemia, and release of cellular and inflammatory mediators that can potentially lead to cystoid macular edema (CME), epiretinal membrane formation, artery and vein occlusions, retinal and choroidal neovascularization, vitreous hemorrhage, tractional retinal detachment, cataract, glaucoma, and so on. [ 1 2 ]…”